Mathematical approach for the optimal expansion of erythroid progenitors in monolayer culture

Journal of Biotechnology

Volumn 161, Issue 3, 2012, Pages 308-319

  Lahoti, Varun ^a   Murphy, William ^a   Al Rubeai, Mohamed ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Erythroid; Expansion CD34+; Gompertz; Mathematical; Monolayer culture

Indexed keywords

CONTINUOUS PRODUCTION; COST ANALYSIS; CULTURE CONDITIONS; ERYTHROID; EX-VIVO; EXPANSION FACTORS; EXPANSION PROCESS; GOMPERTZ; GOMPERTZ FUNCTION; GROWTH CURVES; MATHEMATICAL; MATHEMATICAL APPROACH; MATHEMATICAL EXPRESSIONS; MONOLAYER CULTURE; OPERATION MODE; OPTIMISATIONS; PERIPHERAL BLOOD; PROCESS ECONOMICS; RED BLOOD CELL; SCALE-UP; SPECIFIC GROWTH RATE;

COST ACCOUNTING; MONOLAYERS;

OPTIMIZATION;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL KINETICS; COST BENEFIT ANALYSIS; ERYTHROCYTE; ERYTHROID PRECURSOR CELL; INOCULATION; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL;

ANTIGENS, CD34; CELL COUNT; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; ERYTHROID PRECURSOR CELLS; HUMANS; KINETICS; MODELS, BIOLOGICAL; TIME FACTORS;

EID: 84864568840     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2012.06.003     Document Type: Article

References (23)

1. Baek E.J., Kim H.-S., Kim J.-H., Kim N.J., Kim H.O. Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer. Transfusion 2009, 49:2285-2295.
2. + cells. Transfusion 2008, 48:2235-2245.
3. + cells for ex vivo red blood cell production. Journal of Biotechnology 2009, 144:127-134.
4. Buchanan R.L., Whiting R.C., Damert W.C. When is simple good enough: a comparison of the Gompertz Baranyi, and three-phase linear models for fitting bacterial growth curves. Food Microbiology 1997, 14:313-326.
5. Cohn C.S., Cushing M.M. Oxygen therapeutics: perfluorocarbons and blood substitute safety. Critical Care Clinics 2009, 25:399-414.
6. Deakin M.A. Gompertz curves, allometry and embryogenesis. Bulletin of Mathematical Biophysics 1970, 32:445-452.
7. Douay L., Andreu G. Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion?. Transfusion Medicine Reviews 2007, 21:91-100.
8. + cells by co-culturing with macrophages. International Journal of Hematology 2008, 87:339-350.
9. Giarratana M., Kobari L., Lapillonne H., Chalmers D., Kiger L., Cynober T., Marden M., Wajcman H., Douay L. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nature Biotechnology 2005, 23:69-74.
10. Gordon M.Y., Marley S.B., Davidson R.J., Grand F.H., Lewis J.L., Nguyen D.X., Lloyd S., Goldman J.M. Contact-mediated inhibition of human haematopoietic progenitor cell proliferation may be conferred by stem cell antigen, CD34. Hematology Journal 2000, 1:77.
11. Greenburg A.G. The ideal blood substitute. Critical Care Clinics 2009, 25:415-424.
12. Heegaard S., Spang-Thomsen M., Prause J.U. Establishment and characterization of human uveal malignant melanoma xenografts in nude mice. Melanoma Research 2003, 13:247-251.
13. + hematopoietic stem and progenitor cells by use of a new serum-free medium. Transfusion 2006, 46:126-131.
14. Kasper C., van Griensven M., Pörtner R., Melero-Martin J.M., Santhalingam S., Al-Rubeai M. Methodology for Optimal In Vitro Cell Expansion in Tissue Engineering Bioreactor Systems for Tissue Engineering 2009, Springer Berlin, Heidelberg, pp. 209-229.
15. Kim H.O., Baek E.J. Red blood cell engineering in stroma and serum/plasma-free conditions and long term storage. Tissue Engineering Part A 2011, 18:117-126.
16. Lloyd H.H. Estimation of tumor cell kill from Gompertz growth curves. Cancer Chemotherapy Reports. Part 1 1975, 59:267-277.
17. Loh Y.-H., Agarwal S., Park I.-H., Urbach A., Huo H., Heffner G.C., Kim K., Miller J.D., Ng K., Daley G.Q. Generation of induced pluripotent stem cells from human blood. Blood 2009, 113:5476-5479.
18. Melero-Martin J.M., Dowling M.-A., Smith M., Al-Rubeai M. Optimal in vitro expansion of chondroprogenitor cells in monolayer culture. Biotechnology and Bioengineering 2006, 93:519-533.
19. Melero-Martin J.M., Khan Z.A., Picard A., Wu X., Paruchuri S., Bischoff J. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 2007, 109:4761-4768.
20. Neildez-Nguyen T.M.A., Wajcman H., Marden M.C., Bensidhoum M., Moncollin V., Giarratana M.-C., Kobari L., Thierry D., Douay L. Human erythroid cells produced ex vivo at large scale differentiate into red blood cells in vivo. Nature Biotechnology 2002, 20:467-472.
21. Spratt J.A., von Fournier D., Spratt J.S., Weber E.E. Decelerating growth and human breast cancer. Cancer 1993, 71:2013-2019.
22. Staerk J., Dawlaty M.M., Gao Q., Maetzel D., Hanna J., Sommer C.A., Mostoslavsky G., Jaenisch R. Reprogramming of human peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010, 7:20-24.
23. Timmins N.E., Nielsen L.K. Blood cell manufacture: current methods and future challenges. Trends in Biotechnology 2009, 27:415-422.